aa-clozapine tablet
aa pharma inc - clozapine - tablet - 25mg - clozapine 25mg - atypical antipsychotics
aa-clozapine tablet
aa pharma inc - clozapine - tablet - 100mg - clozapine 100mg - atypical antipsychotics
auro-clozapine tablet
auro pharma inc - clozapine - tablet - 25mg - clozapine 25mg - atypical antipsychotics
auro-clozapine tablet
auro pharma inc - clozapine - tablet - 50mg - clozapine 50mg - atypical antipsychotics
auro-clozapine tablet
auro pharma inc - clozapine - tablet - 100mg - clozapine 100mg - atypical antipsychotics
auro-clozapine tablet
auro pharma inc - clozapine - tablet - 200mg - clozapine 200mg - atypical antipsychotics
aa-clozapine tablet
aa pharma inc - clozapine - tablet - 50mg - clozapine 50mg - atypical antipsychotics
aa-clozapine tablet
aa pharma inc - clozapine - tablet - 200mg - clozapine 200mg - atypical antipsychotics
clozapine tablet
accord healthcare inc. - clozapine (unii: j60ar2ikic) (clozapine - unii:j60ar2ikic) - clozapine 25 mg - clozapine is indicated for the treatment of severely ill patients with schizophrenia who fail to respond adequately to standard antipsychotic treatment. because of the risks of severe neutropenia and of seizure associated with its use, clozapine should be used only in patients who have failed to respond adequately to standard antipsychotic treatment [see warnings and precautions (5.1, 5.5)] . the effectiveness of clozapine in treatment-resistant schizophrenia was demonstrated in a 6-week, randomized, double-blind, active-controlled study comparing clozapine and chlorpromazine in patients who had failed other antipsychotics [see clinical studies (14.1)] . clozapine is indicated for reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder who are judge
clozapine tablet
sandoz inc. - clozapine (unii: j60ar2ikic) (clozapine - unii:j60ar2ikic) - clozapine 25 mg - clozapine tablets are indicated for the treatment of severely ill patients with schizophrenia who fail to respond adequately to standard antipsychotic treatment. because of the risks of severe neutropenia and of seizure associated with its use, clozapine tablets should be used only in patients who have failed to respond adequately to standard antipsychotic treatment [see warnings and precautions (5.1, 5.5)] . the effectiveness of clozapine tablets in treatment-resistant schizophrenia was demonstrated in a 6-week, randomized, double-blind, active-controlled study comparing clozapine and chlorpromazine in patients who had failed other antipsychotics [see clinical studies (14.1)] . clozapine tablets are indicated for reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder who are judged to be at chronic risk for re-experiencing suicidal behavior, based on history and recent clinical state. suicidal behavior refers to actions by a patient that put him/herself at